Harb Tarek相关文献与解析，生知库 | 链接生命科学的每一步

Nasrallah, Nadim; Harb, Tarek; Atallah, Mark; Gerstenblith, Gary; Haberlen, Sabina; Kelesidis, Theodoros; Magnani, Jared W; Stosor, Valentina; Chan, Kenneth; Shirodaria, Cheerag; West, Henry W; Brown, Todd T; Hays, Allison G; Post, Wendy S; Antoniades, Charalambos; Leucker, Thorsten M

HIV

炎症/感染

炎症

微生物学

发表日期：2026

文献求助收藏

Impact of In-Hospital PCSK9 Inhibition on Myocardial Inflammation After Myocardial Infarction: A Randomized Clinical Trial

院内PCSK9抑制剂对心肌梗死后心肌炎症的影响：一项随机临床试验

期刊:Jacc-Basic To Translational Science

影响因子:7.2

doi:10.1016/j.jacbts.2025.03.010

Ziogos, Efthymios; Harb, Tarek; Valenta, Ines; Vavuranakis, Michael A; Foran, Palmer L; Williams, Marlene S; Blaha, Michael J; Hays, Allison G; Jones, Steven R; Schindler, Thomas H; Schulman, Steven P; Gerstenblith, Gary; Leucker, Thorsten M

炎症

心肌炎

炎症/感染

Immunology/Inflammation

Advanced biologic therapies and cardiovascular events in patients with inflammatory bowel disease

炎症性肠病患者的先进生物疗法与心血管事件

期刊:American Journal of Preventive Cardiology

影响因子:5.9

doi:10.1016/j.ajpc.2025.100991

Chaaban, Lara; Harb, Tarek; Gerstenblith, Gary; Leucker, Thorsten M; Melia, Joanna

Increased lipoprotein(a) levels independently predict a higher incidence of ventricular arrhythmias: A comprehensive retrospective cohort study

脂蛋白(a)水平升高可独立预测室性心律失常的发生率：一项全面的回顾性队列研究

期刊:Heart Rhythm O2

影响因子:2.9

doi:10.1016/j.hroo.2025.07.001

Sani, Maryam M; Harb, Tarek; Leucker, Thorsten M; Chrispin, Jonathan

发表日期：2025

文献求助收藏

Neurocardiac Axis Physiology and Clinical Applications

神经心脏轴生理学及临床应用

期刊:IJC Heart and Vasculature

影响因子:2.5

doi:10.1016/j.ijcha.2024.101488

Plott, Caroline; Harb, Tarek; Arvanitis, Marios; Gerstenblith, Gary; Blumenthal, Roger; Leucker, Thorsten

发表日期：2024

文献求助收藏

Peroxisome Proliferator-Activated Receptor Gamma Regulates Interleukin-6-Induced Lipoprotein (a) Gene Expression in Human HepG2 Cells

过氧化物酶体增殖激活受体γ调节人HepG2细胞中白细胞介素-6诱导的脂蛋白(a)基因表达

期刊:Journal of Cardiovascular Pharmacology

影响因子:2.2

doi:10.1097/FJC.0000000000001634

Harb, Tarek; Ziogos, Efthymios; Amat-Alarcon, Núria; Lai, Shenghan; Gerstenblith, Gary; Arvanitis, Marios; Leucker, Thorsten M

Intra-individual variability in lipoprotein(a): the value of a repeat measure for reclassifying individuals at intermediate risk

脂蛋白(a)的个体内部变异性：重复测量对重新分类中等风险个体的价值

期刊:European Heart Journal Open

影响因子:

doi:10.1093/ehjopen/oeae064

Harb, Tarek; Ziogos, Efthymios; Blumenthal, Roger S; Gerstenblith, Gary; Leucker, Thorsten M

发表日期：2024

文献求助收藏

Homocysteine modifies the association of coronary stenosis and HIV infection in an inner city African American population

同型半胱氨酸会影响非裔美国人城市贫困人口中冠状动脉狭窄与 HIV 感染之间的关联

期刊:International Journal of Std & Aids

影响因子:

doi:10.1177/09564624241242171

Leucker, Thorsten M; Harb, Tarek; Gerstenblith, Gary; Celentano, David D; Ziogos, Efthymios; Treisman, Glenn; Mandler, Raul N; Khalsa, Jag; Charurat, Man; Lai, Shenghan; Lai, Hong

Rapid Improvement of Coronary Endothelial Function With PCSK9 Inhibition in People With HIV Is Associated With Reduced Lipoprotein (a) and Not LDL-cholesterol

在 HIV 感染者中，PCSK9 抑制剂可快速改善冠状动脉内皮功能，这与脂蛋白 (a) 降低有关，而与低密度脂蛋白胆固醇 (LDL-C) 降低无关。

期刊:Circulation-Cardiovascular Imaging

影响因子:7

doi:10.1161/CIRCIMAGING.123.015693

Harb, Tarek; Ziogos, Efthymios; Schär, Michael; Brown, Todd T; Lai, Shenghan; Gerstenblith, Gary; Hays, Allison G; Leucker, Thorsten M

Platelet activation and endothelial dysfunction biomarkers in acute coronary syndrome: the impact of PCSK9 inhibition.

急性冠脉综合征中血小板活化和内皮功能障碍生物标志物：PCSK9 抑制的影响

期刊:European Heart Journal-Cardiovascular Pharmacotherapy

影响因子:6.1

doi:10.1093/ehjcvp/pvad051

Ziogos Efthymios, Chelko Stephen P, Harb Tarek, Engel Morgan, Vavuranakis Michael A, Landim-Vieira Maicon, Walsh Elise M, Williams Marlene S, Lai Shenghan, Halushka Marc K, Gerstenblith Gary, Leucker Thorsten M

其它

发表日期：2023

文献求助收藏

Lipoprotein(a) is associated with coronary inflammation in people with HIV and undetectable HIV RNA

脂蛋白(a)与HIV感染者（HIV RNA检测不到）的冠状动脉炎症相关。

Impact of In-Hospital PCSK9 Inhibition on Myocardial Inflammation After Myocardial Infarction: A Randomized Clinical Trial

院内PCSK9抑制剂对心肌梗死后心肌炎症的影响：一项随机临床试验

Advanced biologic therapies and cardiovascular events in patients with inflammatory bowel disease

炎症性肠病患者的先进生物疗法与心血管事件

Increased lipoprotein(a) levels independently predict a higher incidence of ventricular arrhythmias: A comprehensive retrospective cohort study

脂蛋白(a)水平升高可独立预测室性心律失常的发生率：一项全面的回顾性队列研究

Neurocardiac Axis Physiology and Clinical Applications

神经心脏轴生理学及临床应用

Peroxisome Proliferator-Activated Receptor Gamma Regulates Interleukin-6-Induced Lipoprotein (a) Gene Expression in Human HepG2 Cells

过氧化物酶体增殖激活受体γ调节人HepG2细胞中白细胞介素-6诱导的脂蛋白(a)基因表达

Intra-individual variability in lipoprotein(a): the value of a repeat measure for reclassifying individuals at intermediate risk

脂蛋白(a)的个体内部变异性：重复测量对重新分类中等风险个体的价值

Homocysteine modifies the association of coronary stenosis and HIV infection in an inner city African American population

同型半胱氨酸会影响非裔美国人城市贫困人口中冠状动脉狭窄与 HIV 感染之间的关联

Rapid Improvement of Coronary Endothelial Function With PCSK9 Inhibition in People With HIV Is Associated With Reduced Lipoprotein (a) and Not LDL-cholesterol

在 HIV 感染者中，PCSK9 抑制剂可快速改善冠状动脉内皮功能，这与脂蛋白 (a) 降低有关，而与低密度脂蛋白胆固醇 (LDL-C) 降低无关。

Platelet activation and endothelial dysfunction biomarkers in acute coronary syndrome: the impact of PCSK9 inhibition.

急性冠脉综合征中血小板活化和内皮功能障碍生物标志物：PCSK9 抑制的影响